InspireMD, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD -37.55 M

InspireMD, Inc. EBIT is USD -37.55 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 55.32% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • InspireMD, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -24.18 M, a 29.92% change year over year.
  • InspireMD, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -18.61 M, a 17.12% change year over year.
  • InspireMD, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -15.89 M, a 34.60% change year over year.
  • InspireMD, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -11.80 M, a 35.57% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)